Antiviral effects of antisense morpholino oligomers in murine coronavirus infection models

被引:74
作者
Burrer, Renaud
Neuman, Benjamin W.
Ting, Joey P. C.
Stein, David A.
Moulton, Hong M.
Iversen, Patrick L.
Kuhn, Peter
Buchmeier, Michael J.
机构
[1] Scripps Res Inst, Dept Mol & Integrat Neurosci, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA
[3] AVI Biopharma Inc, Corvallis, OR 97333 USA
关键词
D O I
10.1128/JVI.02360-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The recent emergence of novel pathogenic human and animal coronaviruses has highlighted the need for antiviral therapies that are effective against a spectrum of these viruses. We have used several strains of murine hepatitis virus (MHV) in cell culture and in vivo in mouse models to investigate the antiviral characteristics of peptide-conjugated antisense phosphorodiamidate morpholino oligomers (P-PMOs). Ten P-PMOs directed against various target sites in the viral genome were tested in cell culture, and one of these (5TERM), which was complementary to the 5' terminus of the genomic RNA, was effective against six strains of MHV. Further studies were carried out with various arginine-rich peptides conjugated to the 5TERM PMO sequence in order to evaluate efficacy and toxicity and thereby select candidates for in vivo testing. In uninfected mice, prolonged P-PMO treatment did not result in weight loss or detectable histopathologic changes. 5TERM P-PMO treatment reduced viral titers in target organs and protected mice against virus-induced tissue damage. Prophylactic 5TERM P-PMO treatment decreased the amount of weight loss associated with infection under most experimental conditions. Treatment also prolonged survival in two lethal challenge models. In some cases of high-dose viral inoculation followed by delayed treatment, 5TERM P-PMO treatment was not protective and increased morbidity in the treated group, suggesting that P-PMO may cause toxic effects in diseased mice that were not apparent in the uninfected animals. However, the strong antiviral effect observed suggests that with further development, P-PMO may provide an effective therapeutic approach against a broad range of coronavirus infections.
引用
收藏
页码:5637 / 5648
页数:12
相关论文
共 40 条
[1]   16,16-DIMETHYL PROSTAGLANDIN-E2 PREVENTS THE DEVELOPMENT OF FULMINANT-HEPATITIS AND BLOCKS THE INDUCTION OF MONOCYTE MACROPHAGE PROCOAGULANT ACTIVITY AFTER MURINE HEPATITIS-VIRUS STRAIN-3 INFECTION [J].
ABECASSIS, M ;
FALK, JA ;
MAKOWKA, L ;
DINDZANS, VJ ;
FALK, RE ;
LEVY, GA .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (03) :881-889
[2]   Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents [J].
Abes, Said ;
Moulton, Hong M. ;
Clair, Philippe ;
Prevot, Paul ;
Youngblood, Derek S. ;
Wu, Rebecca P. ;
Iversen, Patrick L. ;
Lebleu, Bernard .
JOURNAL OF CONTROLLED RELEASE, 2006, 116 (03) :304-313
[3]   RNA recognition and cleavage by the SARS coronavirus endoribonuclease [J].
Bhardwaj, Kanchan ;
Sun, Jingchuan ;
Holzenburg, Andreas ;
Guarino, Linda A. ;
Kao, C. Cheng .
JOURNAL OF MOLECULAR BIOLOGY, 2006, 361 (02) :243-256
[4]   The glycosylation status of the murine hepatitis coronavirus M protein affects the interferogenic capacity of the virus in vitro and its ability to replicate in the liver but not the brain [J].
de Haan, CAM ;
de Wit, M ;
Kuo, L ;
Montalto-Morrison, C ;
Haagmans, BL ;
Weiss, SR ;
Masters, PS ;
Rottier, PJM .
VIROLOGY, 2003, 312 (02) :395-406
[5]   Inhibition of flavivirus infections by antisense oligorners specifically suppressing viral translation and RNA replication [J].
Deas, TS ;
Binduga-Gajewska, I ;
Tilgner, M ;
Ren, P ;
Stein, DA ;
Moulton, HM ;
Iversen, PL ;
Kauffman, EB ;
Kramer, LD ;
Shi, PY .
JOURNAL OF VIROLOGY, 2005, 79 (08) :4599-4609
[6]   VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice [J].
Enterlein, S ;
Warfield, KL ;
Swenson, DL ;
Stein, DA ;
Smith, JL ;
Gamble, CS ;
Kroeker, AD ;
Iversen, PL ;
Bavari, S ;
Mühlberger, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (03) :984-993
[7]   Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomers [J].
Ge, Qing ;
Pastey, Manoj ;
Kobasa, Darwyn ;
Puthavathana, Piliapan ;
Lupfer, Christopher ;
Bestwick, Richard K. ;
Iversen, Patrick L. ;
Chen, Jianzhu ;
Stein, David A. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (11) :3724-3733
[8]   Severe acute respiratory syndrome coronavirus phylogeny: toward consensus [J].
Gorbalenya, AE ;
Snijder, EJ ;
Spaan, WJM .
JOURNAL OF VIROLOGY, 2004, 78 (15) :7863-7866
[9]   Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China [J].
Guan, Y ;
Zheng, BJ ;
He, YQ ;
Liu, XL ;
Zhuang, ZX ;
Cheung, CL ;
Luo, SW ;
Li, PH ;
Zhang, LJ ;
Guan, YJ ;
Butt, KM ;
Wong, KL ;
Chan, KW ;
Lim, W ;
Shortridge, KF ;
Yuen, KY ;
Peiris, JSM ;
Poon, LLM .
SCIENCE, 2003, 302 (5643) :276-278
[10]   Modulation of the pharmacokinetic properties of PNA:: Preparation of galactosyl, mannosyl, fucosyl, N-acetylgalactosaminyl, and N-acetylglucosaminyl derivatives of aminoethylglycine peptide nucleic acid monomers and their incorporation into PNA oligomers [J].
Hamzavi, R ;
Dolle, F ;
Tavitian, B ;
Dahl, O ;
Nielsen, PE .
BIOCONJUGATE CHEMISTRY, 2003, 14 (05) :941-954